What is BioCryst Pharmaceuticals's inventory write down?

BioCryst Pharmaceuticals (BCRX) reported inventory write down of $74K in Q1 2026.

How has BioCryst Pharmaceuticals's inventory write down changed year-over-year?

BioCryst Pharmaceuticals's inventory write down decreased by 64.6% year-over-year, from $209K to $74K.

What does inventory write down mean?

The expense recognized when the carrying value of inventory is reduced because it is deemed obsolete, damaged, or its market value has fallen below cost. This metric highlights potential inefficiencies in supply chain management or shifts in product demand.

BioCryst Pharmaceuticals BCRX Inventory Write Down

Inventory Write Down at other companies

John Wiley & Sons, Inc.WLYB

$2.18M-21.6%

Boston BeerSAM

$3.43M-37.4%

SolarEdge TechnologiesSEDG

$4.46M-97.6%

BioCryst PharmaceuticalsBCRX

$74K-64.6%

ADMA BiologicsADMA

$2.1M—

Oceaneering InternationalOII

$0-100%

Other financials

Income statement

See full

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InventoryWriteDown.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's inventory write down.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioCryst Pharmaceuticals's inventory write down?: BioCryst Pharmaceuticals (BCRX) reported inventory write down of $74K in Q1 2026.
How has BioCryst Pharmaceuticals's inventory write down changed year-over-year?: BioCryst Pharmaceuticals's inventory write down decreased by 64.6% year-over-year, from $209K to $74K.
What does inventory write down mean?: The expense recognized when the carrying value of inventory is reduced because it is deemed obsolete, damaged, or its market value has fallen below cost. This metric highlights potential inefficiencies in supply chain management or shifts in product demand.